Prediction of human pharmacokinetics —gastrointestinal absorption
- 1 July 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 59 (7), 905-916
- https://doi.org/10.1211/jpp.59.7.0001
Abstract
Permeability (P(e)) and solubility/dissolution are two major determinants of gastrointestinal (GI) drug absorption. Good prediction of these is crucial for predicting doses, exposures and potential interactions, and for selecting appropriate candidate drugs. The main objective was to evaluate screening methods for prediction of GI P(e), solubility/dissolution and fraction absorbed (f(a)) in humans. The most accurate P(e) models for prediction of f(a) of passively transported and highly soluble compounds appear to be the 2/4/A1 rat small intestinal cell model (in-vitro and in-silico), a newly developed artificial-membrane method, and a semi-empirical approach based on in-vitro membrane affinity to immobilized lipid bilayers, effective molecular weight and physiological GI variables. The predictability of in-vitro Caco-2, in-situ perfusion and other artificial membrane methods seems comparably low. The P(e) and f(a) in humans for compounds that undergo mainly active transport were predicted poorly by all models investigated. However, the rat in-situ perfusion model appears useful for prediction of active uptake potential (complete active uptake is generally well predicted), and Caco-2 cells are useful for studying bidirectional active transport, respectively. Human intestinal in-vitro P(e), which correlates well with f(a) for passively transported compounds, could possibly also have potential to improve/enable predictions of f(a) for actively transported substances. Molecular descriptor data could give an indication of the passive absorption potential. The 'maximum absorbable dose' and 'dose number' approaches, and solubility/dissolution data obtained in aqueous media, appear to underestimate in-vivo dissolution to a considerable extent. Predictions of in-vivo dissolution should preferably be done from in-vitro dissolution data obtained using either real or validated simulated GI fluids.Keywords
This publication has 81 references indexed in Scilit:
- Prediction of human pharmacokinetics – evaluation of methods for prediction of volume of distributionJournal of Pharmacy and Pharmacology, 2007
- A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry**This work was presented at the American Association of Pharmaceutical Scientists Annual meeting, Salt Lake City, USA, Oct. 26, 2003.Journal of Pharmaceutical Sciences, 2006
- Clinical pharmacokinetics of the cyclooxygenase inhibiting nitric oxide donator (CINOD) AZD3582Journal of Pharmacy and Pharmacology, 2005
- Cell culture-based models for intestinal permeability: A critiqueDrug Discovery Today, 2005
- Utility of metabolic stability screening: comparison ofin vitroandin vivoclearanceXenobiotica, 2001
- MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability ScreeningJournal of Pharmaceutical Sciences, 1999
- QUANTITATIVE PREDICTION OF IN VIVO DRUG CLEARANCE AND DRUG INTERACTIONS FROM IN VITRO DATA ON METABOLISM, TOGETHER WITH BINDING AND TRANSPORTAnnual Review of Pharmacology and Toxicology, 1998
- Membrane Transport of Drugs in Different Regions of the Intestinal Tract of the RatJournal of Pharmaceutical Sciences, 1998
- Comparison between active and passive drug transport in human intestinal epithelial (caco-2) cells in vitro and human jejunum in vivoInternational Journal of Pharmaceutics, 1996
- Measurement of Jejunal Surface pH in Situ by Plastic pH Electrode in Patients with Coeliac DiseaseScandinavian Journal of Gastroenterology, 1987